Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Evaluation of Pain Relief and Bacterial Reduction After Using Calcium Hydroxide With Mesoporous Silica Nanoparticles as an Intracanal Medicament in Necrotic Mandibular Molars: A Randomized Controlled Clinical Trial [NA]

View source ↗

Summary

A randomized controlled trial is evaluating pain relief and bacterial reduction when using calcium hydroxide combined with mesoporous silica nanoparticles as an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium hydroxide with mesoporous silica nanoparticles (intracanal medicament) (calcium hydroxide with mesoporous silica nanoparticles)

Snippet

Sponsor: Future University in Egypt | Conditions: Necrotic Pulp | NA | Status: ACTIVE_NOT_RECRUITING